TransMedicsvsThermo Fisher Scientific

TMDX and TMO stock compared: price, dividend, valuation and results, from SEC filings.

TMDX

TransMedics Group, Inc.

$92.21

Value $3.2B

+0.91%
TMDX's page

TMO

Thermo Fisher Scientific Inc

$691.33

Value $257B

-1.27%
TMO's page

TransMedics (TMDX) has a market value of $3.2B and Thermo Fisher Scientific (TMO) $257B. Over the last year, with dividends, TMDX moved -19.8% and TMO +19.9%. Dividend yield: TMDX none, TMO 0.27%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    TMDX$3.2B

    TMO$257B

    TMO is 81 times TMDX

  • Revenue, 12 months

    TMDX$728M

    TMO$47.4B

    TMO is 65 times TMDX

  • Net income, 12 months

    TMDX$144M

    TMO$7.1B

    TMO is 49 times TMDX

  • Operating margin

    TMDX11.9%

    TMO17.9%

    6.0 points apart

  • ROIC

    TMDX7.2%

    TMO8.2%

    1.0 points apart

  • P/E

    TMDX–

    TMO36.3

  • Dividend yield

    TMDX0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    TMDX+258.4%

    TMO+10.9%

    247.5 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

TMDX+258.4%

TMO+10.9%

20040060020222023202420252026
Returns by period
PeriodTMDXWith dividendsTMOWith dividends
1 year since November 14, 2025-19.8%Price -19.8%+19.9%Price +19.5%
3 years since November 16, 2023+38.1%+11.4% a yearPrice +38.1%+47.7%+13.9% a yearPrice +46.3%
5 years since November 15, 2021+258.4%+29.1% a yearPrice +258.4%+10.9%+2.1% a yearPrice +9.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

TMDXTransMedicsTMOThermo Fisher Scientific

Valuation

TMDXTMO
Valuation
Price$92.21$691.33
Market value$3.2B$257B
Enterprise value (EV)$3.5B$292B
P/E–36.3
P/E, 5-year median–32.7
P/B5.74.7
EV/EBIT40.934.5
Free cash flow yield1.4%3.0%

Results and growth

TMDXTMO
Results and growth
Revenue, 12 months$728M$47.4B
Net income, 12 months$144M$7.1B
Free cash flow, 12 months$45M$7.6B
Earnings per share, 12 months$3.66$18.96
Revenue growth, year on year37.1%3.9%
Revenue growth a year, past+88.2%over 5 years+6.7%over 5 years
EPS growth a year, past–+2.1%over 5 years

Margins and returns on capital

TMDXTMO
Margins and returns on capital
Gross margin58.6%–
Operating margin11.9%17.9%
Net margin19.9%14.9%
ROIC7.2%8.2%
ROE30.2%13.4%

Balance sheet

TMDXTMO
Balance sheet
Cash$493M$6.1B
Total debt$867M$41.4B
Net debt / EBITDA3.23.7
Interest cover3.5×5.5×

Dividends and buybacks

TMDXTMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield–1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: TMDX or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, TransMedics or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($257B) is about 81.2 times TransMedics ($3.2B), at today's prices.

How did TMDX and TMO stock do over the last 5 years?

Since November 15, 2021, TMDX's price moved +258.4% and TMO's +9.3%. With dividends: TMDX +258.4% (+29.1% a year), TMO +10.9% (+2.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, TMDX or TMO?

The dividend yield at today's price is none for TransMedics and 0.27% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

Which has the higher profit margins, TransMedics or Thermo Fisher Scientific?

Over the last twelve months, the net margin was 19.9% for TransMedics and 14.9% for Thermo Fisher Scientific, and the operating margin 11.9% and 17.9%. Revenue was $728M and $47.4B.

Which is the better investment, TransMedics or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.